Cardiff Oncology, Inc.CRDFNASDAQ
LOADING
|||
Key Metrics
As of 2024• vs 2023
Per Share
Revenue/Share
$0.01+31.2%
Net Income/Share
$-0.95-2.8%
Operating CF/Share
$-0.79-14.4%
Free CF/Share
$-0.79-12.5%
Cash/Share
$1.93+15.0%
Book Value/Share
$1.74+11.5%
Tangible Book/Share
$1.74+11.5%
Equity/Share
$1.74+11.5%
Interest Debt/Share
$0.03-33.6%
Valuation
Market Cap
$206.80M+212.8%
Enterprise Value
P/E Ratio$156.85M+236.5%
-4.55-185.3%
P/S Ratio302.78+123.5%
P/OCF Ratio
-5.49-156.3%
P/FCF Ratio
P/B Ratio-5.47-160.6%
2.49+162.9%
P/TB Ratio
EV/Sales2.49+162.9%
229.65+140.4%
EV/EBITDA
-3.25-213.9%
Profitability
Earnings Yield-21.97%+64.9%
FCF Yield-18.27%+61.6%
ROE-54.77%+7.8%
ROIC-57.59%+8.8%
Return on Tangible Assets-46.74%+7.9%
Capital Allocation
CapEx/OCF
-0.21%+88.7%
CapEx/Revenue
11.71%-90.2%
CapEx/Depreciation
0.20-86.5%
SBC/Revenue
696.93%-24.6%
Balance Sheet
Debt/Equity0.02-40.4%
Debt/Assets0.02-40.5%
Net Debt/EBITDA
Current Ratio1.04+138.9%
7.08-4.5%
Interest Coverage0.00x
Income Quality0.83+11.3%
Efficiency
Days Sales Outstanding
413 days+91.8%
Days Payables Outstanding
0 days
Days Inventory
0 days
Receivables Turnover
0.88x-47.9%
Payables Turnover
0.00x
Inventory Turnover
0.00x
Special Valuations
Graham Number
--
Graham Net-Net
$1.64+16.0%